69 results on '"Puhan, Milo A."'
Search Results
2. Is Statistical Significance Alone Obsolete?: Let’s Turn to Meaningful Interpretation of Scientific and Real-world Evidence on Surgical Care
3. Causal Mediation Analysis with Multiple Time-varying Mediators
4. How to Establish Benchmarks for Surgical Outcomes?: A Checklist Based on an International Expert Delphi Consensus
5. Interleukin-6 Is an Early Plasma Marker of Severe Postoperative Complications in Thoracic Surgery: Exploratory Results From a Substudy of a Randomized Controlled Multicenter Trial
6. Anesthesia and Circulating Tumor Cells in Primary Breast Cancer Patients: A Randomized Controlled Trial
7. Can Early Postoperative Complications Predict High Morbidity and Decrease Failure to Rescue Following Major Abdominal Surgery?
8. Can Early Postoperative Complications Predict High Morbidity and Decrease Failure to Rescue Following Major Abdominal Surgery?
9. Anesthesia and Circulating Tumor Cells in Primary Breast Cancer Patients: A Randomized Controlled Trial
10. Defining Global Benchmarks in Bariatric Surgery: A Retrospective Multicenter Analysis of Minimally Invasive Roux-en-Y Gastric Bypass and Sleeve Gastrectomy
11. Procedural Surgical RCTs in Daily Practice: Do Surgeons Adopt Or Is It Just a Waste of Time?
12. Defining Global Benchmarks in Bariatric Surgery: A Retrospective Multicenter Analysis of Minimally Invasive Roux-en-Y Gastric Bypass and Sleeve Gastrectomy
13. Procedural Surgical RCTs in Daily Practice: Do Surgeons Adopt Or Is It Just a Waste of Time?
14. Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons
15. Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons
16. The Comprehensive Complication Index (CCI®) is a Novel Cost Assessment Tool for Surgical Procedures
17. Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results
18. Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results
19. Commonly Used Patient-Reported Outcomes Do Not Improve Prediction of COPD Exacerbations: A Multicenter 4½ Year Prospective Cohort Study
20. Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts
21. THE AUTHORS REPLY
22. Using a patient-centered approach to benefit–harm assessment in treatment decision-making: a case study in uveitis
23. Medical End-of-Life Practices in Switzerland: A Comparison of 2001 and 2013
24. Handgrip weakness and mortality risk in COPD: a multicentre analysis
25. An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation
26. Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis
27. Personalized Respiratory Medicine: Exploring the Horizon, Addressing the Issues. Summary of a BRN-AJRCCM Workshop Held in Barcelona on June 12, 2014
28. Sex Differences in Response to Tadalafil in Pulmonary Arterial Hypertension
29. What does your neighbourhood say about you? A study of life expectancy in 1.3 million Swiss neighbourhoods
30. Variation in Mortality Patterns Among the General Population, Study Participants, and Different Types of Nonparticipants: Evidence From 25 Years of Follow-up
31. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis
32. The ADO Index as a Predictor of Two-Year Mortality in General Practice-Based Chronic Obstructive Pulmonary Disease Cohorts
33. Individual and spousal education, mortality and life expectancy in Switzerland: a national cohort study
34. Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study
35. Determinants and outcomes of physical activity in patients with COPD: a systematic review
36. Benefits and harms of roflumilast in moderate to severe COPD
37. Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002–2012
38. No Association of 25-Hydroxyvitamin D With Exacerbations in Primary Care Patients With COPD
39. Consumer involvement in systematic reviews of comparative effectiveness research
40. An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
41. Pulmonary rehabilitation after an exacerbation of chronic obstructive pulmonary disease – Evidence for the applicability of trial results to practice populations
42. Patient characteristics and physician-determined variables affecting saphenofemoral reflux recurrence after ligation and stripping of the great saphenous vein
43. Reply: A Call to Apply the Minimal Important Difference in Pulmonary Arterial Hypertension beyond the Flawed 6-Minute-Walk Test
44. Moving from Evidence to Developing Recommendations in Guidelines: Article 11 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report
45. Synthesis, Grading, and Presentation of Evidence in Guidelines: Article 7 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report
46. Deciding What Type of Evidence and Outcomes to Include in Guidelines: Article 5 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report
47. Does pharmacological conditioning with the volatile anaesthetic sevoflurane offer protection in liver surgery?
48. How to Use an Article Reporting a Multiple Treatment Comparison Meta-analysis
49. The Minimal Important Difference in the 6-Minute Walk Test for Patients with Pulmonary Arterial Hypertension
50. Early versus Late Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Patients with Acute Exacerbations: A Randomized Trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.